Back to Trades
Total Value
$23.9K
Net $11.0K sold
Filing Date
Jul 20, 2026
1 transaction
Sales
$11.0K
1 transaction
Trade Summary
On Jul 17, 2026, Rodman David Malcom, Chief Medical Officer, sold $23.9K of Mineralys Therapeutics, Inc. (MLYS) across 1 transaction. The filing covers Common Stock and reflects net selling of $11.0K. Reported prices ranged from $15.44 to $26.53. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Mineralys Therapeutics, Inc.
- Ticker Symbol
- MLYS
- CIK
- 0001933414
Insider Information
- Role
- Chief Medical Officer
- Location
- RADNOR, PA
Filing Details
- Filing Date
- Jul 20, 2026
- Transaction Date
- Jul 17, 2026
- Accession Number
- 0001672659-26-000036
- Form Type
- 4
- Net Trading Amount
- -$11.0K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 17, 2026 | Common Stock | 416 | $15.44 | Exercise | $6.4K |
| Jul 17, 2026 | Common Stock | 416 | $26.53 | Sale | $11.0K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 17, 2026 | MLYS derivative | 416 | $15.44 | Exercise | $6.4K |
Want live alerts when Rodman David Malcom trades again?
Download Insider Trades to track MLYS, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.
- (F2)The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.